🔎 Trials Near Me

Home › Metastatic Cancer › Iowa

Pag-aaral pangklinika para sa Metastatic Cancer sa Iowa

10 pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa mga site sa Iowa.

Mga Lungsod sa Iowa

Opisyal na teksto ng pag-aaral (English)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
  • at 4 pa
Nagre-recruitPhase 2
Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564377

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

  • Research Site, Des Moines
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06103864

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • University of Iowa, Iowa City
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07174336

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  • University of Iowa, Iowa City
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07029399

A Study of ASP1002 in Adults for Treatment of Solid Tumors

  • University of Iowa Hospitals, Iowa City
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT05719558

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

  • University of Iowa Health Care, Iowa City
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT05283330

5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors

  • University of Iowa Health Care, Iowa City
Nagre-recruitPhase 1
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update May 28, 2026 · NCT07404332

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

  • University of Iowa, Iowa City
Nagre-recruitPhase 2/3
Lahat ng edad · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT06581406

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

  • University of Iowa Hospitals & Clinics- Holden Comprehensive Cancer Center, Iowa City
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 6, 2026 · NCT06127407

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Iowa City
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.